Editor's Correspondence |

Underutilization of Lipid-Lowering Therapy in Coronary Artery Disease

Alberto Batalla, MD; Sergio Hevia, MD; Julián R. Reguero, MD; Gustavo I. Cubero, MD
Arch Intern Med. 2000;160(17):2683-2684. doi:.
Text Size: A A A
Published online


Miller et al1 found relatively low treatment rates of hyperlipidemia among patients with coronary artery disease in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT). Several large prospective placebo-controlled clinical trials with statins showed benefit in the risk of recurrent coronary events in patients with established coronary heart disease.24 In addition to lowering low-density lipoprotein (LDL) cholesterol levels, statin therapy appears to exhibit pleiotropic effects on many components of atherosclerosis, including plaque thrombogenicity, cellular migration, endothelial function, and thrombotic tendency.5 Some studies have demonstrated a high prevalence of modifiable risk factors in coronary heart disease as well as considerable potential to reduce the risk of a further major ischemic event in patients.68 In Spain, the PREVESE study6 (secondary prevention of myocardial infarction in Spain) found a very small percentage of lipid-lowering prescription (6.7%) at discharge among 1242 patients with myocardial infarction.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles